FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Anand Rathi has given "Apply" recommendation to Neogen Chemicals IPO. Capital Market, Dilip Davda, Kotak Securities, Mehta Equities and SMC Global have given "May Apply" recommendation to Neogen Chemicals IPO. Angel One has "Neutral" view about the IPO. Choice Equity Broking Pvt Ltd and S P Tulsian recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 1 | 5 | 1 | 2 | 0 |
% | 11.11 | 55.56 | 11.11 | 22.22 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Anand Rathi | Apply | |
Angel One | Neutral | |
Capital Market | May Apply | |
Choice Equity Broking Pvt Ltd | Avoid | |
Dilip Davda | May Apply | |
Kotak Securities | May Apply | |
Mehta Equities | May Apply | |
SMC Global | May Apply | |
S P Tulsian | Avoid |
The Captial Market (CapitalMarket.com) rating for Neogen Chemicals IPO is 38. Their analysis recommends Do not subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 38 | Do not subscribe |
[Dilip Davda] NCL has created a niche place in the bromine and lithium product segment. The issue appears fully priced on the basis of given financial data. As the company is now in fast forward mode with enhanced capacities, it holds a promising future. Considering these aspects, investors may consider investment for the long term. Read detail review...
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|